ELLEN GENTILE: Open Payments
NPI 1740560762 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,918 in 112 payments from 21 companies in 2025. Trend: 2023 $2,693 · 2024 $1,847 · 2025 $1,918
Food & beverage: $1,918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $421 |
| AstraZeneca Pharmaceuticals LP | 13 | $388 |
| Novo Nordisk Inc | 12 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $139 |
| Axsome Therapeutics, Inc. | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| PFIZER INC. | 4 | $69 |
| Lilly USA, LLC | 4 | $64 |
| Abbott Laboratories | 3 | $61 |
Products named: FARXIGA, UBRELVY, CAPLYTA, QULIPTA, Kerendia, Auvelity, REXULTI, BREZTRI.
Industry payments across LA — which companies pay providers there.
